Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation

European Cells and Materials

Volumn 24, Issue , 2012, Pages 136-153

  Oliveira, Marta I ^a   Santos, Susana G ^a   Oliveira, Maria J ^a   Torres, Ana L ^a   Barbosa, Mário A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cell activation; Chitosan; Dendritic cell; Immune response; Immunomodulation; Inflammation; Macrophage; Polarisation

Indexed keywords

BIOMATERIAL; CD86 ANTIGEN; CHITOSAN; GELATINASE A; GELATINASE B; HLA DR ANTIGEN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; HLA ANTIGEN CLASS 2; IL10 PROTEIN, HUMAN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE ACTIVATION; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE REPAIR; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONOCYTE;

ANTIGENS, CD86; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHITOSAN; DENDRITIC CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-10; MACROPHAGES; MONOCYTES; ORGAN SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868253478     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v024a10     Document Type: Article

References (80)

1. Anderson JM, Jones JA (2007) Phenotypic dichotomies in the foreign body reaction. Biomaterials 28: 5114-5120.
2. Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20: 86-100.
3. Arca HÇ, Günbeyaz M,Şenel S (2009) Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 8: 937-953.
4. Ariganello MB, Simionescu DT, Labow RS, Michael Lee J (2011) Macrophage differentiation and polarization on a decellularized pericardial biomaterial. Biomaterials 32: 439-449.
5. Azab AK, Doviner V, Orkin B, Kleinstern J, Srebnik M, Nissan A, Rubinstein A (2007) Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat. J Biomed Mater Res A 83A: 414-422.
6. Babensee JE (2008) Interaction of dendritic cells with biomaterials. Semin Immunol 20: 101-108.
7. Babensee JE, Paranjpe A (2005) Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 74A: 503-510.
8. Babensee JE, Anderson JM, McIntire LV, Mikos AG (1998) Host response to tissue engineered devices. Adv Drug Deliver Rev 33: 111-139.
9. Baldrick P (2010) The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharm 56: 290-299.
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
11. Barbosa JN, Amaral IF, Águas AP, Barbosa MA (2010) Evaluation of the effect of the degree of acetylation on the inflammatory response to 3D porous chitosan scaffolds. J Biomed Mater Res A 93A: 20-28.
12. Brodbeck WG, Nakayama Y, Matsuda T, Colton E, Ziats NP, Anderson JM (2002) Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine 18: 311-319.
13. Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM (2003) In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A 64A: 320-329.
14. Brodbeck WG, MacEwan M, Colton E, Meyerson H, Anderson JM (2005) Lymphocytes and the foreign body response: Lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A 74A: 222-229.
15. Chang DT, Colton E, Anderson JM (2009) Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation. J Biomed Mater Res A 89A: 490-498.
16. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC (1997) Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27: 431-441.
17. Crompton K, Tomas D, Finkelstein D, Marr M, Forsythe J, Horne M (2006) Inflammatory response on injection of chitosan/GP to the brain. J Mater Sci Mater Med 17: 633-639.
18. Dash M, Chiellini F, Ottenbrite RM, Chiellini E (2011) Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 36: 981-1014.
19. DeFife KM, Jenney CR, Colton E, Anderson JM (1999) Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J Histochem Cytochem 47: 65-74.
20. Dinnes DLM, Santerre JP, Labow RS (2008) Influence of biodegradable and non-biodegradable material surfaces on the differentiation of human monocyte-derived macrophages. Differentiation 76: 232-244.
21. Fabriek BO, Møller HJ, Vloet RPM, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BMJ, van den Berg TK, Dijkstra CD (2007) Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmunol 187: 179-186.
22. Fainaru O, Shay T, Hantisteanu S, Goldenberg D, Domany E, Groner Y (2007) TGF[beta]-dependent gene expression profile during maturation of dendritic cells. Genes Immun 8: 239-244.
23. Feng J, Zhao L, Yu Q (2004) Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem Biophys Res Commun 317: 414-420.
24. Fiani ML, Beitz J, Turvy D, Blum JS, Stahl PD (1998) Regulation of mannose receptor synthesis and turnover in mouse J774 macrophages J Leukoc Biol 64: 85-91.
25. Goetzl E, Banda M, Leppert D (1996) Commentary: Matrix metalloproteinases in immunity. J Immunol 156: 1-4.
26. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
27. Gretzer C, Gisselfält K, Liljensten E, Rydén L, Thomsen P (2003) Adhesion, apoptosis and cytokine release of human mononuclear cells cultured on degradable poly(urethane urea), polystyrene and titanium in vitro. Biomaterials 24: 2843-2852.
28. Guzmán-Morales J, Ariganello MB, Hammami I, Thibault M, Jolicoeur M, Hoemann CD (2011) Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 405: 538-544.
29. Han Y, Zhao L, Yu Z, Feng J, Yu Q (2005) Role of mannose receptor in oligochitosan-mediated stimulation of macrophage function. Int Immunopharmacol 5: 1533-1542.
30. Hidaka Y, Ito M, Mori K, Yagasaki H, Kafrawy AH (1999) Histopathological and immunohistochemical studies of membranes of deacetylated chitin derivatives implanted over rat calvaria. J Biomed Mater Res 46: 418-423.
31. Higgins DM, Basaraba RJ, Hohnbaum AC, Lee EJ, Grainger DW, Gonzalez-Juarrero M (2009) Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 175: 161-170.
32. Huber S, Hoffmann R, Muskens F, Voehringer D (2010) Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 116: 3311-3320.
33. Jones JA, Chang DT, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM (2007) Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 83A: 585-596.
34. Jones JA, McNally AK, Chang DT, Qin LA, Meyerson H, Colton E, Kwon ILK, Matsuda T, Anderson JM (2008) Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 84A: 158-166.
35. Kang ML, Cho CS, Yoo HS (2009) Application of chitosan microspheres for nasal delivery of vaccines. Biotechnol Adv 27: 857-865.
36. Kim I-Y, Seo S-J, Moon H-S, Yoo M-K, Park I-Y, Kim B-C, Cho C-S (2008) Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 26: 1-21.
37. Kim H, Tator CH, Shoichet MS (2011) Chitosan implants in the rat spinal cord: Biocompatibility and biodegradation. J Biomed Mater Res A 97A: 395-404.
38. Kou PM, Babensee JE (2011) Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A 96A: 239-260.
39. Larsen C, Ritchie S, Hendrix R, Linsley P, Hathcock K, Hodes R, Lowry R, Pearson T (1994) Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152: 5208-5219.
40. León B, López-Bravo M, Ardavín C (2005) Monocyte-derived dendritic cells. Semin Immunol 17: 313-318.
41. Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E, Bianchi ME, Cossu G, Manfredi AA, Brunelli S, Rovere-Querini P (2009) Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1-and MMP-9-dependent pathways. J Leukoc Biol 85: 779-787.
42. Mangi RJ, Kantor FS (1975) The multiple mixed lymphocyte reaction: variables important in the test as a measure of lymphocyte competence in man. Yale J Biol Med 48: 217-228.
43. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
44. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23: 344-346.
45. Martínez-Pomares L, Mahoney JA, Káposzta R, Linehan SA, Stahl PD, Gordon S (1998) A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. J Biol Chem 273: 23376-23380.
46. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13: 453-461.
47. Mesure L, De Visscher G, Vranken I, Lebacq A, Flameng W (2010) Gene expression study of monocytes/ macrophages during early foreign body reaction and identification of potential precursors of myofibroblasts. PLoS ONE 5: e12949.
48. Mori T, Okumura M, Matsuura M, Ueno K, Tokura S, Okamoto Y, Minami S, Fujinaga T (1997) Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials 18: 947-951.
49. Mori T, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T (2005) Mechanism of macrophage activation by chitin derivatives. J Vet Med Sci 67: 51-56.
50. Muzzarelli RAA (2009) Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohyd Polym 76: 167-182.
51. Nishimura K, Ishihara C, Ukei S, Tokura S, Azuma I (1986) Stimulation of cytokine production in mice using deacetylated chitin. Vaccine 4: 151-156.
52. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M-r, Gorman D, Wagner J, Zurawski S, Liu Y-J, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
53. Peluso G, Petillo O, Ranieri M, Santin M, Ambrosic L, Calabró D, Avallone B, Balsamo G (1994) Chitosan-mediated stimulation of macrophage function. Biomaterials 15: 1215-1220.
54. Pioli PA, Goonan KE, Wardwell K, Guyre PM (2004) TGF-ß regulation of human macrophage scavenger receptor CD163 is Smad3-dependent. J Leukoc Biol 76: 500-508.
55. Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.
56. Porporatto C, Bianco ID, Riera CM, Correa SG (2003) Chitosan induces different l-arginine metabolic pathways in resting and inflammatory macrophages. Biochem Biophys Res Comun 304: 266-272.
57. Porporatto C, Bianco ID, Correa SG (2005) Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration J Leukoc Biol 78: 62-69.
58. Porporatto C, Canali MM, Bianco ID, Correa SG (2009) The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen. Clin Exp Immunol 155: 79-87.
59. Rodriguez A, Meyerson H, Anderson JM (2009) Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A 89A: 152-159.
60. Rogers TH, Babensee JE (2011) The role of integrins in the recognition and response of dendritic cells to biomaterials. Biomaterials 32: 1270-1279.
61. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
62. Santos S, Lynch S, Campbell E, Antoniou A, Powis S (2008) Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cells. Arthritis Res Ther 10: R100.
63. Scheinecker C, Machold KP, Majdic O, Höcker P, Knapp W, Smolen JS (1998) Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J Immunol 161: 3966-3973.
64. Schutte RJ, Parisi-Amon A, Reichert WM (2009a) Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 88A: 128-139.
65. Schutte RJ, Xie L, Klitzman B, Reichert WM (2009b) In vivo cytokine-associated responses to biomaterials. Biomaterials 30: 160-168.
66. Slütter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W (2010) Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release 143: 207-214.
67. Steinbach F, Thiele B (1994) Phenotypic investigation of mononuclear phagocytes by flow cytometry. J Immunol Methods 174: 109-122.
68. Tomihata K, Ikada Y (1997) In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 18: 567-575.
69. Ueno H, Mori T, Fujinaga T (2001a) Topical formulations and wound healing applications of chitosan. Adv Drug Deliver Rev 52: 105-115.
70. Ueno H, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T (2001b) Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes. Biomaterials 22: 1667-1673.
71. Ueno H, Nakamura F, Murakami M, Okumura M, Kadosawa T, Fujinaga T (2001c) Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. Biomaterials 22: 2125-2130.
72. van der Lubben IM, Verhoef JC, Borchard G, Junginger HE (2001) Chitosan for mucosal vaccination. Adv Drug Deliver Rev 52: 139-144.
73. VandeVord PJ, Matthew HWT, DeSilva SP, Mayton L, Wu B, Wooley PH (2002) Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 59: 585-590.
74. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M (1997) Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 158: 2919-2925.
75. Walschus U, Hoene A, Patrzyk M, Finke B, Polak M, Lucke S, Nebe B, Schroeder K, Podbielski A, Wilhelm L, Schlosser M (2012) Serum profile of pro-and anti-inflammatory cytokines in rats following implantation of low-temperature plasma-modified titanium plates. J Mater Sci Mater Med 23: 1299-1307.
76. Webster NL, Crowe SM (2006) Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 80: 1052-1066.
77. Wei X, Wang Y, Zhu Q, Xiao J, Xia W (2009) Effects of chitosan pentamer and chitosan hexamer in vivo and in vitro on gene expression and secretion of cytokines. Food Agric Immunol 20: 269-280.
78. Xia Z, Triffitt JT (2006) A review on macrophage responses to biomaterials. Biomed Mater 1: 1-9.
79. Yussof SJM, Halim AS, Saad AZM, Jaafar H (2011) Evaluation of the biocompatibility of a bilayer chitosan skin regenerating template, human skin allograft, and integra implants in rats. Mater Sci 2011: ID 857483.
80. Muzzarelli RA (2010) Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar Drugs 8: 292-312.